Mutations of the P53 gene in acute myeloid leukaemia - PubMed (original) (raw)
Mutations of the P53 gene in acute myeloid leukaemia
P Fenaux et al. Br J Haematol. 1992 Feb.
Abstract
In a previous report we found point mutations in exons 5-8 of the P53 gene in five of 46 patients with acute myeloid leukaemia (AML), with a predominance of mutations in the 10 patients with 17p monosomy. In this report we extended our findings studying such mutations in 66 unselected additional cases of AML, using polymerase chain reaction single strand conformation polymorphism (SSCP) analysis and nucleotide sequencing. Three of the 66 new cases had a point mutation, leading to a change in one encoded amino acid. Thus, eight of the 112 AML studied had P53 mutations in exons 5-8, suggesting that the incidence of P53 mutation is relatively low in AML. A predominance of mutations in exon 8 (5/8) was found. Six of the eight patients with mutations were older than 60 years of age, and all eight cases had a short survival. All seven mutated cases karyotyped showed complex cytogenetic findings, especially monosomy 5 and/or 7, thus questioning the pathogenic importance of P53 mutations in a context of multiple genetic abnormalities. However, five of them also had 17p monosomy, and in the remaining two cases SSCP and sequence analysis also suggested loss of the normal P53 allele. This supported a role for the P53 gene mutations in leukaemogenesis in the relatively small number of AML patients in whom they were found, through loss of tumour suppressive activity of both normal P53 alleles, as reported in solid tumours.
Similar articles
- P53 gene mutations in acute myeloid leukemia with 17p monosomy.
Fenaux P, Jonveaux P, Quiquandon I, Laï JL, Pignon JM, Loucheux-Lefebvre MH, Bauters F, Berger R, Kerckaert JP. Fenaux P, et al. Blood. 1991 Oct 1;78(7):1652-7. Blood. 1991. PMID: 1912553 - Analysis of p53 gene mutations in acute myeloid leukemia.
Trecca D, Longo L, Biondi A, Cro L, Calori R, Grignani F, Maiolo AT, Pelicci PG, Neri A. Trecca D, et al. Am J Hematol. 1994 Aug;46(4):304-9. doi: 10.1002/ajh.2830460409. Am J Hematol. 1994. PMID: 8037181 - Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations.
Lai JL, Preudhomme C, Zandecki M, Flactif M, Vanrumbeke M, Lepelley P, Wattel E, Fenaux P. Lai JL, et al. Leukemia. 1995 Mar;9(3):370-81. Leukemia. 1995. PMID: 7885035 - The non-random distribution of point mutations in leukaemia and myelodysplasia--a possible pointer to their aetiology.
Parry TE. Parry TE. Leuk Res. 1997 Jun;21(6):559-74. doi: 10.1016/s0145-2126(97)83221-3. Leuk Res. 1997. PMID: 9279367 Review.
Cited by
- TP53 Alterations in Myelodysplastic Syndromes and Acute Myeloid Leukemia.
Rahmé R, Braun T, Manfredi JJ, Fenaux P. Rahmé R, et al. Biomedicines. 2023 Apr 11;11(4):1152. doi: 10.3390/biomedicines11041152. Biomedicines. 2023. PMID: 37189770 Free PMC article. Review. - Specific subtype distribution with impact on prognosis of TP53 single-hit and double-hit events in AML and MDS.
Stengel A, Haferlach T, Baer C, Hutter S, Meggendorfer M, Kern W, Haferlach C. Stengel A, et al. Blood Adv. 2023 Jul 11;7(13):2952-2956. doi: 10.1182/bloodadvances.2022009100. Blood Adv. 2023. PMID: 36735768 Free PMC article. - The clinical impact of the molecular landscape of acute myeloid leukemia.
Kayser S, Levis MJ. Kayser S, et al. Haematologica. 2023 Feb 1;108(2):308-320. doi: 10.3324/haematol.2022.280801. Haematologica. 2023. PMID: 36722402 Free PMC article. Review. - TP53 Expression and Mutational Analysis in Hematological Malignancy in Jeddah, Saudi Arabia.
Alkhatabi H, Yasin EB, Mirza Z, Alserihi R, Felimban R, Elaimi A, Shaabad M, Alharbi L, Ahmed H, Alameer AM, Mathkoor AE, Barefah AS. Alkhatabi H, et al. Diagnostics (Basel). 2022 Mar 16;12(3):724. doi: 10.3390/diagnostics12030724. Diagnostics (Basel). 2022. PMID: 35328276 Free PMC article. - A unique role of p53 haploinsufficiency or loss in the development of acute myeloid leukemia with FLT3-ITD mutation.
Yang M, Pan Z, Huang K, Büsche G, Liu H, Göhring G, Rumpel R, Dittrich-Breiholz O, Talbot S, Scherr M, Chaturvedi A, Eder M, Skokowa J, Zhou J, Welte K, von Neuhoff N, Liu L, Ganser A, Li Z. Yang M, et al. Leukemia. 2022 Mar;36(3):675-686. doi: 10.1038/s41375-021-01452-6. Epub 2021 Nov 3. Leukemia. 2022. PMID: 34732858 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous